NoV(GII.13)VP1 Product List
Host Species
- Mouse（1）
Conjugate
- Unconjugated（1）
Reactive Species
- Virus（1）
Applications
- ELISA（1）
| Molecule | Cat. No. | Product Name | Host Species | Reactive Species | Applications | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|
| NoV(GII.13)VP1 | Monoclonal Anti-Human NoV(GII.13)VP1 Antibody, Mouse IgG1 (2B10) |  Mouse | Virus | $400.00 100ug |   |
You Have Viewed 1-1 Of 1 Results
Asset Licensing Opportunity
Resources
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| SHR-9146 | HTI-1090; SHR-9146 | Phase 1 Clinical | Solid tumours; Neoplasms | Details | |
| LPM-3480226 | LY-01013; LPM-3480226 | Phase 1 Clinical | Luye Pharma Group Ltd | Solid tumours | Details |
| DN-1406131 | DN-131; DN-1406131 | Phase 1 Clinical | Jiangxi Qingfeng Pharmaceutical Industry Co Ltd, Shanghai De Novo Pharmatech Co Ltd | Solid tumours; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
Customer Reviews